Curis Lifesciences launched its Rs 27.5 crore SME IPO on November 7, aiming to raise funds for infrastructure expansion and working capital. The company, which focuses on contract manufacturing and exports, reported strong revenue and profit growth in FY25. The IPO will close on November 11, with shares set to list on the NSE SME platform on November 14.